Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer

PharmacoEconomics - United Kingdom
doi 10.2165/11535560-000000000-00000
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2004English

Bone-Targeted Therapy in Metastatic Breast Cancer - All Well-Established Knowledge?

Breast Care
SurgeryOncology
2014English

Targeted Therapy for Breast Cancer Prevention

Frontiers in Oncology
Cancer ResearchOncology
2013English

Bone Marrow Endothelium-Targeted Therapeutics for Metastatic Breast Cancer

Journal of Controlled Release
Pharmaceutical Science
2014English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Cost-Effectiveness of Proton Therapy for Esophageal Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

A Systematic Review of the Cost-Effectiveness of Targeted Therapies for Metastatic Non-Small Cell Lung Cancer (NSCLC)

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2014English

CXCR4-targeted Therapy in Breast Cancer

The Lancet Oncology
Oncology
2018English

Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis

Oncologist
Cancer ResearchMedicineOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy